We are continuously striving for excellence for lung transplant patients, their primary supporters in Australia.
Funding and facilitating translational research that improves the patient & primary caregiver journey, post-transplant survival rates and/or outcomes for lung transplant recipients.
Advocating to establish a world-leading value-based system of transplant excellence and care that improves the experience and outcomes for patients and primary supporters.
Building a strong community, with long-term strategic partnerships, that provides support for patients, primary supporters, their families and supporters irrespective of where they are based in Australia.
To facilitate, undertake and publish medical and health research for lung transplantation, and where appropriate other human organ transplants, to address the clinical syndrome of Chronic Lung Allograft Dysfunction (CLAD) and associated diseases and medical conditions including, but not limited to, Bronchiolitis Obliterans Syndrome (BOS), Restrictive Allograft Syndrome (RAS), Cytomegalovirus (CMV) disease, fungal diseases and associated complications; together with promoting and supporting improvements in medical procedures, treatments and strategies for patients pre, during and post-transplantation; and
To maximise the range of choices and opportunities to enrich the quality of their lives of people who need or receive a lung transplant, and/or other organ transplants, and their carers with the aim of reducing patient morbidity and mortality.
Learn more about Our Impact.